Bumpus Namandje
- SEC CIK
- 0002060594
In the past year, 2 open-market sale filings worth $28.1K and no purchases.
Current role at each company
- RXRX Recursion Pharmaceuticals, Inc.Directoras of Jun 22, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $28.1K
- 2 filings
- Net
- −$28.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Bumpus Namandje as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 (view filing) | Jun 18 | 4 days | Bumpus NamandjeDirector | SSaleClass A Common Stock | −3.96K | $3.18 | −$12.6K | −3.0%127.6K after | 10b5-1 |
| Jun 4, 2026 (view filing) | Jun 3 | 1 day | Bumpus NamandjeDirector | SSaleClass A Common Stock | −4.39K | $3.54 | −$15.5K | −9.2%43.2K after | 10b5-1 |